Last updated on September 2017

Efficacy and Safety of GDC-0853 in Participants With Refractory Chronic Spontaneous Urticaria (CSU)


Brief description of study

The purpose this study is to evaluate the efficacy, safety, and pharmacokinetics of GDC-0853 compared with placebo in participants with Chronic Spontaneous Urticaria (CSU) refractory to anti-histamines.

Clinical Study Identifier: NCT03137069

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Reference study Id Number: GS39684 ...

Sussman Clinical Research
Toronto, ON Canada
  Connect »

Reference study Id Number: GS39684 ...

Centre de Recherche Applique En Allergie de Quebec
Quebec City, QC Canada
  Connect »

Reference study Id Number: GS39684 ...

Charite Mitte; Klinik fur Dermatologie
Berlin, Germany
  Connect »

Reference study Id Number: GS39684 ...

Universit tsmedizin Johannes Gutenberg Universit t
Mainz, Germany
  Connect »